NCT02433977View on ClinicalTrials.gov

The Effects of NOx and Conjugated Linoleic Acid on Asthmatics

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Asthma
Interventions
DIETARY_SUPPLEMENT

Conjugated Linolenic Acid

CLA is a polyunsaturated fatty acid Subjects will receive capsules for daily oral administration at the dose of 3 g/day

DRUG

Sodium Nitrite

Subjects will receive capsules for daily oral administration at the dose of 20 mg (2 x 10 mg)

DRUG

Sodium Nitrate

Subjects will receive capsules for daily oral administration at the dose of 1g (2 x 500 mg)

Trial Locations (1)

15213

The University of Pittsburgh Asthma Institute at UPMC, Pittsburgh

All Listed Sponsors
lead

Gladwin, Mark, MD

INDIV

NCT02433977 - The Effects of NOx and Conjugated Linoleic Acid on Asthmatics | Biotech Hunter | Biotech Hunter